People with acute decompensated heart failure often face a scary moment when they are hospitalized. Their bodies hold onto too much fluid, causing dangerous swelling. Doctors usually give loop diuretics to help them pee out this excess water. But how much medicine to give is often a guess. A new systematic review and meta-analysis looked at five studies involving hospitalized patients to see if a specific strategy works better. This approach, called UNa-guided diuretic titration, adjusts the drug dose based on how much salt the patient is excreting. The results show that this method significantly increased how much fluid patients produced in the first 24 and 48 hours. It also helped them get rid of more salt during that time. These findings matter because getting rid of fluid quickly can relieve the crushing pressure in the lungs and legs that makes patients feel so sick.
Systematic review shows UNa-guided diuretic titration increases short-term diuresis in hospitalized acute decompensated heart failure patientsGuiding diuretic doses helps hospitalized heart failure patients pee out fluid faster
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider UNa-guided titration for short-term diuresis in hospitalized ADHF patients, noting low certainty for clinical outcomes.
This systematic review and meta-analysis examined the effects of UNa-guided diuretic titration in hospitalized patients with acute decompensated heart failure. Five studies were included in the analysis. The primary outcomes assessed were 24- and 48-hour diuresis and natriuresis. Secondary outcomes included congestion relief, renal function, length of stay, rehospitalization, and mortality.
The analysis demonstrated that UNa-guided titration significantly increased 24-hour diuresis with a mean difference of 0.59 (95%CI [0.30-0.87]) and 48-hour diuresis with a mean difference of 0.70 (95%CI [0.37-1.03]). Similarly, 24-hour natriuresis increased by a mean difference of 88 (95%CI [52-124]) and 48-hour natriuresis increased by a mean difference of 138 (95%CI [69-206]).
No significant differences were observed for mortality (RR = 0.99, 95%CI [0.60-1.63]), rehospitalization (RR = 0.90, 95%CI [0.57-1.41]), renal dysfunction, length of stay, or safety outcomes such as hypotension, hypokalemia, and renal worsening (all P > 0.05). The certainty of evidence was moderate for natriuresis and diuresis and low for clinical outcomes. Larger studies are needed to confirm its long-term benefit and feasibility.
What this means for you:
Adjusting diuretic doses based on urine output helps hospitalized heart failure patients eliminate fluid faster safely. More on Acute Decompensated Heart Failure
Natriuresis-guided diuretic protocols improve fluid removal and shorten hospital stays for acute decompensated heart failure patients compared to standard care approaches in this meta-analysis review
Trial shows natriuresis-guided diuretics help heart failure patients
This systematic review and meta-analysis of 831 patients found that natriuresis-guided diuretic protocols significantly enhanced fluid remov…
A review of 831 patients finds that guiding diuretics by sodium output can increase urine output and shorten hospital stays for acute heart …
Renal perfusion pressure trajectories associate with outcomes in acute decompensated heart failure patients receiving PAC-guided therapy
Kidney Pressure Predicts Survival in Heart Failure
This randomized trial enrolled 143 patients with acute decompensated heart failure randomized to PAC-guided therapy.
Tracking blood pressure in the kidneys helps doctors predict who will recover from heart failure and who needs more help sooner.
Furosemide plus hypertonic saline linked to lower biomarker increases after saline load in ADHF
Study in 200 heart failure patients compares two intravenous diuretic treatment approaches
A randomized controlled trial of 200 patients with acute decompensated HFrEF found intravenous furosemide plus small-volume hypertonic salin…
Adding salt water to heart failure diuretics reduced stress markers in patients, but the study did not show if patients felt better or left …
View Original Abstract ↓
BACKGROUND: Diuretic resistance remains a major challenge in acute decompensated heart failure (ADHF). Urinary sodium (UNa) concentration provides an early marker of loop diuretic responsiveness, yet its clinical utility remains uncertain.
METHODS: We conducted a systematic review and meta-analysis (PROSPERO ID: CRD420251175306). PubMed, Embase, Scopus, and CENTRAL were searched from database inception to October 1, 2025, for studies evaluating UNa-guided diuretic titration in hospitalized ADHF patients. Primary outcomes were 24- and 48 h diuresis and natriuresis; secondary outcomes included congestion relief, renal function, length of stay, rehospitalization, and mortality. Data were pooled using random-effects models. Heterogeneity was assessed using I² and χ² statistics. Analyses were performed with the R software (version 4.4.3, meta package). Certainty of evidence was rated using the GRADE framework.
RESULTS: Five studies were included (three RCTs, two observational cohorts). UNa-guided therapy significantly increased 24- and 48 h diuresis (MD = 0.59,95%CI [0.30-0.87] L; MD = 0.70 [0.37-1.03] L) and natriuresis (MD = 88 [52-124] mmol; MD = 138 [69-206] mmol; all P < 0.001). No significant differences were observed in mortality (RR = 0.99 [0.60-1.63]), rehospitalization (RR = 0.90 [0.57-1.41]), renal dysfunction, or length of stay. Safety outcomes, including hypotension, hypokalemia, and renal worsening, were similar (all P > 0.05). Certainty of evidence was moderate for natriuresis/diuresis and low for clinical outcomes.
CONCLUSIONS: UNa-guided diuretic therapy enhances short-term natriuresis and diuresis without increasing adverse events but shows no proven impact on mortality, rehospitalization, or renal outcomes. Larger studies are needed to confirm its long-term benefit and feasibility.
Meta-analysis finds systemic lupus erythematosus elevates coronary artery disease risk
People with lupus face higher heart disease risk but genetics show no direct link
Related in Cardiology
Pharmacist-led telepharmacy may improve medication adherence and reduce blood pressure in patients with NCDs
Pharmacist Led Telepharmacy May Improve Medication Adherence For Chronic Illness
This systematic review analyzed 21 trials involving 5440 participants to evaluate pharmacist-led telepharmacy for managing non-communicable …
Remote pharmacist services through phone or video may help patients with high blood pressure and diabetes stick to their daily medication pl…
IVUS-guided PCI did not significantly reduce target-vessel failure compared to angiography-guided PCI
Trial shows IVUS guidance does not reduce risk for heart patients
This randomized controlled trial of 2020 patients undergoing complex PCI found that IVUS-guided PCI with stent-optimization criteria resulte…
New data suggests that using special ultrasound imaging during complex heart procedures may not lower the risk of major complications.
Patients with post-COVID syndrome face significant thromboembolic risk requiring proactive monitoring and tailored anticoagulant treatments
Anticoagulant Drugs May Help Manage Thromboembolic Risks After COVID-19
This meta-analysis examines the prevalence of thromboembolic events in individuals with post-COVID syndrome. The analysis identifies a signi…
People with post-COVID syndrome may face a higher risk of blood clots, highlighting the need for proactive monitoring and tailored treatment…
SGLT2 inhibitors associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes
SGLT2 inhibitors associated with lower mortality in heart transplant patients
This meta-analysis examined the impact of SGLT2 inhibitor use on outcomes for heart transplant recipients with type 2 diabetes. The authors …
New analysis suggests SGLT2 inhibitors may lower death rates for heart transplant recipients with type 2 diabetes without increasing UTI ris…
From Other Specialties
Fibromyalgia as an oncology comorbidity increases symptom burden and impairs treatment adherence
Fibromyalgia makes managing cancer pain more difficult for patients
This systematic review of 11 studies examines fibromyalgia as a comorbidity in cancer patients. The findings indicate that fibromyalgia cont…
Patients with both fibromyalgia and cancer face higher symptom burdens and may stop life-saving treatments sooner due to intense, amplified …
Physical exam algorithm distinguishes benign anal masses, guides surgical decisions
New Clinical Algorithm Helps Identify Anal Masses and Prolapse
This narrative review proposes a clinical decision algorithm based on physical examination to differentiate benign lesions prolapsing throug…
Doctors can now use a specific physical examination guide to tell the difference between rectal prolapse, hemorrhoids, and other anal condit…
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Heterogeneous definitions and clinical inconsistencies currently hinder the accurate identification of treatment-resistant depression
New ways to define treatment resistant depression are emerging
This narrative review examines the phenotypic definition of treatment-resistant depression (TRD) and its associated biological correlates. T…
Doctors struggle to treat some types of depression because the current definition is inconsistent. New research looks at how biology and beh…